Clinical Trial Update: Inhaled Iloprost, Dynamic Hyperinflation, and Oxidative Stress in COPD Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating inhaled iloprost for COPD has completed, studying effects on dynamic hyperinflation and oxidative stress.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Iloprost (inhaled) (Iloprost)

Snippet

Sponsor: Louisiana State University Health Sciences Center in New Orleans | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: COMPLETED